[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100555811":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":27,"locations":37,"responsibleParty":52,"collaborators":11,"id":54,"slug":55,"hasResults":56,"nctId":57,"briefTitle":58,"officialTitle":58,"acronym":11,"eligibilityCriteria":59,"healthyVolunteers":56,"sex":60,"minAge":61,"maxAge":62,"enrollmentInfo":63,"targetDuration":11,"studyType":66,"phases":67,"briefSummary":58,"conditions":69,"keywords":11,"overallStatus":40,"whyStopped":11,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":80},{"fullName":5,"class":6},"Shanghai Dermatology Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"The Application of Bovine Basic Fibroblast Growth Factor Gel","EXPERIMENTAL",null,[13],"Drug: bFGF",{"label":15,"type":16,"description":11,"interventionNames":17},"Bovine Basic Gel","PLACEBO_COMPARATOR",[18],"Drug: Bovine Basic Gel",[20,25],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"DRUG","bFGF","Half-face randomized control",[9],{"type":21,"name":15,"description":15,"armGroupLabels":26,"otherNames":11},[15],[28,33],{"name":29,"role":30,"phone":31,"phoneExt":11,"email":32},"Haiyan Zhang, MD PhD","CONTACT","18017336573","zhanghaiyan10842@163.com",{"name":34,"role":30,"phone":35,"phoneExt":11,"email":36},"xiuli Wang, MD PhD","18017336663","wangxiuli20150315@163.com",[38],{"facility":39,"status":40,"city":41,"state":11,"zip":11,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Shanghai Skin Disease Hospital","RECRUITING","Shanghai","China","CN",{"type":45,"coordinates":46},"Point",[47,48],121.45806,31.22222,{"lat":48,"lon":47},[51],{"name":29,"role":30,"phone":11,"phoneExt":11,"email":11},{"type":53,"investigatorFullName":11,"investigatorTitle":11,"investigatorAffiliation":11,"oldNameTitle":11,"oldOrganization":11},"SPONSOR","100555811","the-application-of-bovine-basic-fibroblast-growth-factor-gel-in-the-treatment-of-sensitive-skin-100555811",false,"NCT06516939","The Application of Bovine Basic Fibroblast Growth Factor Gel in the Treatment of Sensitive Skin","Inclusion Criteria:\n\n1. Sensitive skin with a diagnosis of persistent erythema and a lactate irritation test score of 2-3\n2. No related skin care products including bovine alkaline fibroblast growth factor were used within 1 month before participating in the experiment, and photoelectric treatment measures were not carried out\n3. Physical sunscreen should be strict during enrollment\n\nExclusion Criteria:\n\n1. Children\n2. Have serious heart, liver, kidney, and blood system diseases, and severe immunocompromise\n3. Patients with mental illness or cancer\n4. Those who have received glucocorticoids, calcineurin inhibitors, topical small molecule drugs, antibiotics or tretinoin within 3 months\n5. Those who are allergic to basic fibroblast growth factor gel and its components\n6. Acute dermatitis of the face and perifolliculitis","ALL","18 Years","60 Years",{"count":64,"type":65},28,"ESTIMATED","INTERVENTIONAL",[68],"NA",[70],"Sensitive Skin","2024-07-23",{"date":73,"type":74},"2024-07-24","ACTUAL",{"date":76,"type":74},"2024-06-10",{"date":78,"type":65},"2024-07-18",{"name":5,"class":6},1]